| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Prince Henrys Institute of Medical Research (J.I., S.P., I.J.C.), Clayton, Victoria 3168, Australia; and Department of Medicine (R.V.C.), Indiana University, Indianapolis, Indiana 46202
Address all correspondence and requests for reprints to: Professor Iain J. Clarke, Prince Henrys Institute of Medical Research, PO Box 5152, Clayton, Victoria 3168, Australia. E-mail: iain.clarke{at}med monash.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In various species, imunohistochemical and in situ hybridization studies have demonstrated LR protein and its messenger RNA (mRNA) in several tissues including the hypothalamus and pituitary gland (21, 22, 23, 24, 25). A major site of leptin action is thought to be the hypothalamus where LR expression is seen in various neuropeptidergic neurons (25, 26, 27). Apart from a role in the regulation of appetite, mechanisms whereby leptin might influence neuroendocrine functions are not yet clear. Leptin could modulate the expression of neuropeptides that regulate the neuroendocrine system within the hypothalamus, but could also act directly on the anterior pituitary (6, 16, 18, 19, 21). In accordance with the latter possibility, LR mRNA has been localized to GH- secreting and PRL-secreting human pituitary adenomas (21). Although RT-PCR analysis showed presence of LR in the ovine pars distalis, there is no detailed information on localization to particular cell types (24). In fact, there have been no immunohistochemical studies in any species to indicate the presence of LR protein in the anterior pituitary gland.
In sheep, an alteration in adiposity generally affects the secretion of GH (28, 29, 30) and gonadotropins (29, 31, 32, 33, 34, 35, 36) with no effect on the plasma levels of PRL (29), TSH, or cortisol (36). It seems possible, therefore, that the gonadotropes and/or somatotropes of the pituitary gland are potential targets for leptin. The HPA axis is up-regulated by undernutrition in rodents (5), but this is not the case in sheep (36, 37). Accordingly, we sought to determine the extent to which somatotropes and gonadotropes express LR-ir in the female sheep pituitary. We also studied, for comparison, LR-ir expression in corticotropes, since the available data suggest that the HPA axis is not regulated by alteration in adiposity, or by leptin administration, in this species.
| Materials and Methods |
|---|
|
|
|---|
Study 1. Four pituitaries (including the median eminence/pars tuberalis) were obtained from adult Corriedale ewes of similar age and weight, during the luteal phase of the estrous cycle. The tissue was collected as previously reported (38). Briefly, the sheep were administered 25,000 IU of heparin iv and were killed 5 min later by an overdose of sodium pentobarbital (2.5 ml/kg body weight, iv) (Lethabarb; May & Baker Pty Ltd, Melbourne, Australia). The heads were flushed with 2 liters of heparinized (12,500 IU/liter) 0.9% saline via carotid arteries followed by 2 liters of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4) and 1.5 liters of 4% paraformaldehyde in PB containing 20% sucrose. The tissues were removed, transferred to a solution containing 4% paraformaldehyde plus 30% sucrose, and left at 4 C for 5 days. The tissues were then frozen on powdered dry ice and kept at -20 C until used. Sections of 20 µm were cut on a cryostat (CM 1850, Leica Corp., Deerfield, IL) at -20 C and thaw-mounted onto gelatin-chrom-coated slides, left overnight at room temperature, and stored at -20 C until processed for immunohistochemistry. Sections (20 µm) of median eminence/pars tuberalis tissue were similarly obtained and stored in cryoprotectant solution at -20 C until processed for free-floating immunohistochemistry.
Study 2. Analysis of the tissue sections in Study 1 revealed that 90% of the gonadotropes expressed LR-ir in the pars tuberalis, whereas only 30% of the gonadotropes were double labeled in the pars distalis. To investigate whether expression of LR-ir in gonadotropes varied across the estrous cycle, additional pituitaries and median eminence/pars tuberalis tissues were collected (as above) during the luteal, follicular, and surge phases of the estrous cycle (n = 3/group) and examined for LR-ir expression.
Antibodies
We used a rabbit polyclonal LR antibody raised against a peptide
corresponding to amino acids 874886 of LR (39), which is common to
both long (OB-Rb) and short (OB-Ra) isoforms of LR. The
characterization and use of the antibody for localization of LR have
been reported previously (23, 39). The specificity of LR-ir in the
sheep anterior pituitary was tested by preabsorption of LR antiserum
with the peptide used for immunization at a final concentration of 5,
10, and 20 µg/ml. The use and specificity of GH and LHß and ACTH
antibodies for the ovine anterior pituitary have been described
previously (38).
Immunohistochemistry
Slide-mounted pituitary tissue sections and free-floating median
eminence/pars tuberalis tissue sections were processed for
immunofluorescence double labeling according to previously reported
protocols (38) with some modification. Briefly, the sections were
washed in 0.05 M PBS to remove the fixative and treated
with 1% sodium borohydride (Sigma-Aldrich Corp.,
St. Louis, MO) in 0.01 M PB for 20 min. After
washing, the sections were incubated in blocking solution (10% normal
goat serum, 1% BSA, 0.1% Triton X-100 in PB) for 30 min and then with
LR antiserum (1:500) overnight at room temperature. After washing in
PBS, the sections were incubated with Texas Red-conjugated goat
antirabbit IgG (1:250, Molecular Probes, Inc.,
Eugene, OR) in PB for 2 h, washed, and then incubated in
blocking solution containing 10% normal donkey serum for 30 min.
Sections were then incubated either with mouse monoclonal anti-ACTH
(1:50, Novacastro, Newcastle on Tyne, UK), anti-LHß (1:2500, kindly
donated by Dr. J. F. Roser, University of California, Davis, CA).
or anti-GH (1:10, kindly donated by Dr. M. Brandon, University of
Melbourne, Australia). After washing, the sections were then incubated
in biotinylated horse antimouse IgG (1:800, DAKO Corp.,
Carpinteria, CA) for 1 h, washed, and then incubated with
fluorescein thiocyanate (FITC)-conjugated avidin (1:500, Pierce Chemical Co., Rockford, IL) for 1 h and washed
again. For the purpose of presenting representative
photomicrographs, one section from both pars distalis and pars
tuberalis of each animal was also stained with 1% Sudan Black B
(Sigma-Aldrich Corp.) for 10 min to block autofluorescence
(40). In addition, and to show that some cells did not express LR-ir,
representative sections processed for LR-ir only were briefly
counterstained with 4',6' diamidine-2-phenylindole dihydrochloride
(DAPI) for 10 min (1:10, Molecular Probes, Inc., Eugene,
OR). This allowed clear identification of cells that either did or did
not contain LR-ir. The slide-mounted pituitary sections were then
cover-slipped with anti-fade medium (DAKO Corp.).
Free-floating median eminence/pars tuberalis tissue sections were
mounted onto gel-chrome-subbed slides and cover slipped with antifade
medium (DAKO Corp.). Slides were stored at 4 C in the dark
until analyzed. In all cases, negative controls (omission of the
primary antiserum) were run simultaneously to confirm the specificity
of the immunostaining and lack of bleed through of the fluorescent
markers.
Tissue analysis
Tissue analysis was carried out using a BMX 50 microscope
(Olympus Corp., Lake Success, NY) equipped with a mercury
light source and Texas Red and FITC band filter systems to visualize
the red and green immunofluorescence, respectively. The nuclear
staining with DAPI was assessed using the UV light. The expression of
LR-ir within each individual cell labeled either for ACTH, GH, or LHß
was visualized by switching between the Texas Red and FITC filter
systems. To estimate the percentage of cells expressing LR-ir in the
pars distalis, 50 cells were visually counted in each of the five
randomly selected area of a representative section for each animal.
Only cells that had discernable nuclei were counted. There was a clear
difference between cells that stained with either fluorophor and
background, with no cells showing equivocal staining.
To obtain an estimation of the level of expression of LR-ir in somatotropes and gonadotropes, 50 cells were visually counted in each of 5 randomly selected areas in a representative section for each animal. Since ACTH immunoreactive cells are not as abundant, 10 cells were counted in each of 10 randomly selected areas. All observations were made by a single investigator, and each counted cell had a clearly defined nucleus.
Statistical analysis
The data were not corrected for double-labeling cell count (41).
After quantification of LR-immunoreactive cells, the data were
subjected to statistical analysis using one-way ANOVA. Our results
provide a relative number (mean % ± SEM) of each cell
type that is immunopositive for LR and not the actual number of cells
in the pars distalis or pars tuberalis.
| Results |
|---|
|
|
|---|
|
|
Expression of LR-ir was colocalized in 27.5 ± 2.5% of
corticotropes, 69.0 ± 3.3% of somatotropes, and 29.3 ±
2.5% of gonadotropes in the pars distalis (Fig. 3
). In the pars tuberalis,
90.0 ± 1.5% of gonadotropes contained LR-ir (Fig. 4
)(P < 0.01 compared
with pars distalis). No somatotropes were seen in the pars
tuberalis, but a few corticotropes were seen as reported by
Clarke et al. (42); these were not immunopositive for
LR.
|
|
| Discussion |
|---|
|
|
|---|
There is a high level of expression of LR-ir in somatotropes (69%) of the ovine pars distalis and a lower level of expression of LR-ir in corticotropes (27%) and gonadotropes (29%). Since only one third of the gonadotropes were found to express LR in the pars distalis of sheep sampled during the luteal phase (Study 1), it remained possible that expression of LR-ir was regulated by steroids and varied across the estrous cycle. Accordingly, we examined expression of LR-ir in gonadotropes across the luteal, follicular, and estrous phases of the estrous cycle but found no cyclic variation. This strongly suggests that the ovarian steroids do not regulate expression of LR-ir in the gonadotropes.
Only 30% of the gonadotropes express LR-ir in the pars distalis compared with a high (90%) level of expression in the pars tuberalis gonadotropes. The cells of the pars tuberalis are different in embryonic origin and gene expression, and regulation of the cells is different in the two tissues (43). This is exemplified by ontogenetic studies of the distribution of the transcription factor PIT-1 in the rat (44, 45) and studies on the expression of arylalkylamine N-acetyltransferase in the ovine anterior pituitary gland (46). It has also been known for some time that the pars tuberalis contains a very high percentage of gonadotropes (47), but other pituitary cell types are also present (42, 48). In the ovine, the pars tuberalis cells express a high level of melatonin receptors, whereas the pars distalis cells do not (49, 50). Further, it has been reported that variable endocrine conditions do not affect the number and distribution of gonadotropes in the pars tuberalis of the sheep (48), and this also appears to be true for the pars distalis. The high level of LR-ir expression in the pars tuberalis compared with that of the pars distalis could be due to the close proximity of the former to the neural components of the median eminence (hypothalamic neuronal endings) and the primary plexus of the hypophyseal portal system. Thus, it seems most likely that cells of pars tuberalis are differentially regulated to those of pars distalis. The results of the present study provide further evidence of the different phenotypes of gonadotropes in the pars tuberalis and pars distalis of the ovine pituitary.
Studies in vitro and in vivo have suggested that leptin may act directly on the pituitary gland to affect the secretion of GH (6, 7, 8, 16, 17, 21) and gonadotropins (6, 15), but PRL secretion is not altered (21). It is well established that leptin regulates the HPA axis in rodents (5, 6, 18) and may affect TSH levels in humans (19), but this is not the case in the sheep, at least with central administration of leptin (20). Collectively, these studies are in accordance with observations that an alteration in adiposity influences the GH (20, 28, 29, 30) and gonadotropin (LH and FSH) secretion (31, 32, 33, 34, 35, 36) in sheep, with no effect on PRL (29). Whereas the effect of leptin to regulate GH could reflect, in part, altered secretion of somatostatin (30), there could also be direct pituitary regulation as indicated by the in vitro studies (see above). Appropriate in vivo studies to demonstrate direct pituitary action of leptin in relation to GH and gonadotropin secretion remain to be done. The present study strongly suggests that a GH is most likely to be affected by leptin action at this level. The lower level of LR-ir expression in gonadotropes and corticotropes does not provide such a clear-cut indication. Neither is it clear at this stage as to whether these cell types express the short or the long form of the receptor.
The LR exists as multiple splice variants that differ in the length of their intracellular domain (51). The short isoform of the LR is reported to be present in the several peripheral tissues, and the long isoform exists mainly in the hypothalamus where it is thought to mediate signal transduction in the specific neurons (27). Using RT-PCR, presence of the both long and short isoforms of the LR have been demonstrated in the rat, human, and sheep anterior pituitary (21, 22, 23, 24). The LR antiserum we used in the present study recognizes both short and long isoforms of the LR, and further studies are required to determine which form predominates in the ovine anterior pituitary.
In summary, the present study demonstrates localization of LR-ir in the corticotropes (27%), somatotropes (69%), and gonadotropes (29%) of the pars distalis of the ovine anterior pituitary. A high level of expression of LR-ir was found in the gonadotropes (90%) of the pars tuberalis, further demonstrating the special nature of these cells. The proportion of gonadotropes that expressed LR-ir did not change across the luteal, follicular, and surge phases of the estrous cycle, suggesting a lack of regulation by ovarian steroids in the ovine pituitary.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received September 20, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Iqbal, O. Latchoumanin, I. P. Sari, R. J. Lang, H. A. Coleman, H. C. Parkington, and I. J. Clarke Estradiol-17{beta} Inhibits Gonadotropin-Releasing Hormone-Induced Ca2+ in Gonadotropes to Regulate Negative Feedback on Luteinizing Hormone Release Endocrinology, September 1, 2009; 150(9): 4213 - 4220. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Accorsi, A. Munno, M. Gamberoni, R. Viggiani, M. De Ambrogi, C. Tamanini, and E. Seren Role of Leptin on Growth Hormone and Prolactin Secretion by Bovine Pituitary Explants J Dairy Sci, April 1, 2007; 90(4): 1683 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Luque, Z. H. Huang, B. Shah, T. Mazzone, and R. D. Kineman Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E891 - E899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. French, R. P. Littlejohn, G. J. Greer, W. E. Bain, J. C. McEwan, and D. J. Tisdall Growth hormone and ghrelin receptor genes are differentially expressed between genetically lean and fat selection lines of sheep J Anim Sci, February 1, 2006; 84(2): 324 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Maciel, D. A. Zieba, M. Amstalden, D. H. Keisler, J. P. Neves, and G. L. Williams Chronic administration of recombinant ovine leptin in growing beef heifers: Effects on secretion of LH, metabolic hormones, and timing of puberty J Anim Sci, October 1, 2004; 82(10): 2930 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bluher and C. S. Mantzoros The Role of Leptin in Regulating Neuroendocrine Function in Humans J. Nutr., September 1, 2004; 134(9): 2469S - 2474S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.A. Zieba, M. Amstalden, S. Morton, M.N. Maciel, D.H. Keisler, and G.L. Williams Regulatory Roles of Leptin at the Hypothalamic-Hypophyseal Axis Before and after Sexual Maturation in Cattle Biol Reprod, September 1, 2004; 71(3): 804 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kuriyama, S. Takekoshi, K. Tojo, Y. Nakai, M. J. Kuhar, and R. Y. Osamura Cocaine- and Amphetamine-Regulated Transcript Peptide in the Rat Anterior Pituitary Gland Is Localized in Gonadotrophs and Suppresses Prolactin Secretion Endocrinology, May 1, 2004; 145(5): 2542 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Anderson, S. Jeftinija, and C. G. Scanes Growth Hormone Secretion: Molecular and Cellular Mechanisms and In Vivo Approaches Experimental Biology and Medicine, April 1, 2004; 229(4): 291 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. McDuffie, N. Akhter, and G. V. Childs Regulation of Leptin mRNA and Protein Expression in Pituitary Somatotropes J. Histochem. Cytochem., February 1, 2004; 52(2): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.N. Maciel, D.A. Zieba, M. Amstalden, D.H. Keisler, J.P. Neves, and G.L. Williams Leptin Prevents Fasting-Mediated Reductions in Pulsatile Secretion of Luteinizing Hormone and Enhances Its Gonadotropin-Releasing Hormone-Mediated Release in Heifers Biol Reprod, January 1, 2004; 70(1): 229 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amstalden, D.A. Zieba, J.F. Edwards, P.G. Harms, T.H. Welsh Jr., R.L. Stanko, and G.L. Williams Leptin Acts at the Bovine Adenohypophysis to Enhance Basal and Gonadotropin-Releasing Hormone-Mediated Release of Luteinizing Hormone: Differential Effects Are Dependent upon Nutritional History Biol Reprod, November 1, 2003; 69(5): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Wettemann, C. A. Lents, N. H. Ciccioli, F. J. White, and I. Rubio Nutritional- and suckling-mediated anovulation in beef cows J Anim Sci, February 1, 2003; 81(14_suppl_2): E48 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanobe Leptin directly acts within the hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo in rats J. Physiol., November 15, 2002; 545(1): 255 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kilciler, M. Ozata, C. Oktenli, S.Y. Sanisoglu, E. Bolu, N. Bingol, M. Kilciler, I. C. Ozdemir, and M. Kutlu Diurnal Leptin Secretion Is Intact in Male Hypogonadotropic Hypogonadism and Is Not Influenced by Exogenous Gonadotropins J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5023 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanobe and S. Habu Leptin Regulates Growth Hormone-Releasing Factor, Somatostatin, and alpha -Melanocyte-Stimulating Hormone But Not Neuropeptide Y Release in Rat Hypothalamus In Vivo: Relation with Growth Hormone Secretion J. Neurosci., July 15, 2002; 22(14): 6265 - 6271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baratta, R. Saleri, G. L. Mainardi, D. Valle, A. Giustina, and C. Tamanini Leptin Regulates GH Gene Expression and Secretion and Nitric Oxide Production in Pig Pituitary Cells Endocrinology, February 1, 2002; 143(2): 551 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Roh, G.-Y. Nie, K. Loneragan, A. Gertler, and C. Chen Direct Modification of Somatotrope Function by Long-Term Leptin Treatment of Primary Cultured Ovine Pituitary Cells Endocrinology, December 1, 2001; 142(12): 5167 - 5171. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |